UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.409-418

2017

Volltextzugriff (PDF)

Feasibility of Patient Reporting of Symptomatic Adverse Events via the PRO-CTCAE in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

International journal of radiation oncology, biology, physics, 2017-02, Vol.98 (2), p.409-418

2017

Volltextzugriff (PDF)

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy–Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012

International journal of radiation oncology, biology, physics, 2017-03, Vol.97 (4), p.786-796

2017

Volltextzugriff (PDF)

Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: dose-volume histogram analysis

The cancer journal (Sudbury, Mass.), 2002-11, Vol.8 (6), p.451

2002

Volltextzugriff (PDF)

A Randomized Phase II Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012

International journal of radiation oncology, biology, physics, 2016-11, Vol.97 (4), p.786-796

2016

Volltextzugriff (PDF)

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system

World journal of surgical oncology, 2014-05, Vol.12 (1), p.162-162

2014

Volltextzugriff (PDF)

CB-16MALIGNANT GLIOMA WITH PRIMITIVE NEUROECTODERMAL COMPONENTS: CLINICAL AND PATHOLOGIC FEATURES OF FIVE CASES

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v44-v44

2014

Volltextzugriff (PDF)

Dissociative electron attachment cross sections for halofluoromethanes

The Journal of chemical physics, 1995-01, Vol.102 (1), p.119-123

1995

Volltextzugriff (PDF)

CB-16 MALIGNANT GLIOMA WITH PRIMITIVE NEUROECTODERMAL COMPONENTS: CLINICAL AND PATHOLOGIC FEATURES OF FIVE CASES

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v44-v44

2014

Volltextzugriff (PDF)

Photochemical charge transfer excitation of trans-4-stilbazole at a silver electrode

Surface science, 1999-10, Vol.440 (3), p.357-374

1999

Volltextzugriff (PDF)

Diagnostic dilemmas in oncology: case 3. Pericardial effusion after esophageal radiation

Journal of clinical oncology, 2001-12, Vol.19 (23), p.4344-4345

2001

Volltextzugriff (PDF)

A Randomized Phase II Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis During the Treatment of Lung Cancer: Results of Trial

International journal of radiation oncology, biology, physics, 2016

2016

Volltextzugriff (PDF)

On the Origin and Headward Extension of First-Order Channels

Journal of geography (Houston), 1969-02, Vol.68 (2), p.100-105

1969

Volltextzugriff (PDF)

THE REGIONALIZATION OF TIDAL MARSHES ALONG THE EASTERN COAST OF THE UNITED STATES

GERGEL, THOMAS JOSEPH

1969

Volltextzugriff (PDF)

On the Origin and Headward Extension of First Of der Channels

Journal of geography (Houston), 1969-02, Vol.68 (2), p.100-105

1969

Volltextzugriff (PDF)

Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1

Molecular cancer therapeutics, 2016-12, Vol.15 (12), p.2946-2954

2016

Volltextzugriff (PDF)

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Cancer Immunology, Immunotherapy, 2019-02, Vol.68 (2), p.233-245

2019

Volltextzugriff (PDF)

Map Misclassification Can Cause Large Errors in Landscape Pattern Indices: Examples from Habitat Fragmentation

Ecosystems (New York), 2006-04, Vol.9 (3), p.474-488

2006

Volltextzugriff (PDF)

New projections of 21st century climate and hydrology for Alaska and Hawaiʻi

Climate services, 2022-08, Vol.27, p.100312, Article 100312

2022

Volltextzugriff (PDF)

Abstract 3816: Efficacy of CDX-1140, an agonist CD40 antibody, in preclinical tumor models

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3816-3816

2018

Volltextzugriff (PDF)

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

JAMA : the journal of the American Medical Association, 1998-01, Vol.279 (4), p.287

1998

Volltextzugriff (PDF)

Abstract 3217: Preclinical evaluation of the recombinant dendritic cell growth factor CDX-301 (Flt3L), and AST-008, a TLR9 agonist SNA

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3217-3217

2019

Volltextzugriff (PDF)

Abstract 253: Synergistic antitumor activity of PD-1 signaling blockade and CD27 costimulation correlates with enhanced ratio of effector to regulatory T cells at the tumor site

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.253-253

2015

Volltextzugriff (PDF)

Abstract 2649: Development of an antibody-drug conjugate targeting TIM-1 for the treatment of ovarian and renal cell carcinoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2649-2649

2014

Volltextzugriff (PDF)

Preclinical Efficacy of an Antibody‐Drug Conjugate Targeting TIM‐1 in Ovarian, Renal and Lung Tumor Models

The FASEB journal, 2015-04, Vol.29 (S1)

2015

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Humans
(8)
Life Sciences & Biomedicine
(8)
Female
(6)
Male
(6)
Oncology
(6)
Aged
(4)
Middle Aged
(4)
Biological And Medical Sciences
(3)
Chemotherapy
(3)
Combined Modality Therapy
(3)
Radiotherapy
(3)
Adult
(2)
Animals
(2)
Antibodies
(2)
Antibodies, Monoclonal - Immunology
(2)
Antibodies, Monoclonal - Pharmacology
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cancer
(2)
Care And Treatment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

Feasibility of Patient Reporting of Symptomatic Adverse Events via the PRO-CTCAE in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy–Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012

Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: dose-volume histogram analysis

A Randomized Phase II Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system

CB-16MALIGNANT GLIOMA WITH PRIMITIVE NEUROECTODERMAL COMPONENTS: CLINICAL AND PATHOLOGIC FEATURES OF FIVE CASES

Dissociative electron attachment cross sections for halofluoromethanes

CB-16 MALIGNANT GLIOMA WITH PRIMITIVE NEUROECTODERMAL COMPONENTS: CLINICAL AND PATHOLOGIC FEATURES OF FIVE CASES

Photochemical charge transfer excitation of trans-4-stilbazole at a silver electrode

Diagnostic dilemmas in oncology: case 3. Pericardial effusion after esophageal radiation

A Randomized Phase II Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis During the Treatment of Lung Cancer: Results of Trial

On the Origin and Headward Extension of First-Order Channels

THE REGIONALIZATION OF TIDAL MARSHES ALONG THE EASTERN COAST OF THE UNITED STATES

On the Origin and Headward Extension of First Of der Channels

Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Map Misclassification Can Cause Large Errors in Landscape Pattern Indices: Examples from Habitat Fragmentation

New projections of 21st century climate and hydrology for Alaska and Hawaiʻi

Abstract 3816: Efficacy of CDX-1140, an agonist CD40 antibody, in preclinical tumor models

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

Abstract 3217: Preclinical evaluation of the recombinant dendritic cell growth factor CDX-301 (Flt3L), and AST-008, a TLR9 agonist SNA

Abstract 253: Synergistic antitumor activity of PD-1 signaling blockade and CD27 costimulation correlates with enhanced ratio of effector to regulatory T cells at the tumor site

Abstract 2649: Development of an antibody-drug conjugate targeting TIM-1 for the treatment of ovarian and renal cell carcinoma

Preclinical Efficacy of an Antibody‐Drug Conjugate Targeting TIM‐1 in Ovarian, Renal and Lung Tumor Models

Suchergebnisse filtern